VEGF-C–induced lymphangiogenesis also participates in antitumor immune responses and tumor metastasis, inflammatory bowel diseases, and neurodegenerative and neuroinflammatory diseases (2, 3). This evidence concerns the gene VEGFC and neoplasm.